Ana Maria Cuervo

Ana Maria Cuervo

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Ana Maria Cuervo

Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2008 in Nature
Verified
Journal Article
Closed access
PDF file
NMNoboru Mizushima
Noboru Mizushima
BLBeth Levine
Beth Levine
ACAna Maria Cuervo
Ana Maria Cuervo
DKDaniel J. Klionsky
Daniel J. Klionsky

1 April 2009 in Nature
Verified
Journal Article
Closed access
PDF file
RSRajat Singh
Rajat Singh
SKSusmita Kaushik
Susmita Kaushik
YWYongjun Wang
Yongjun Wang
YXYouqing Xiang
Youqing Xiang
INInna Novak
Inna Novak
MCMark J. Czaja
Mark J. Czaja

1 November 2014 in Cell
Verified
Journal Article
Closed access
BKBrian K. Kennedy
Brian K. Kennedy
SBShelley L. Berger
Shelley L. Berger
ABAnne Brunet
Anne Brunet
JCJudith Campisi
Judith Campisi
ACAna Maria Cuervo
Ana Maria Cuervo
FSFelipe Sierra
Felipe Sierra

16 February 2008 in Autophagy
Verified
Journal Article
Closed access
DKDaniel J. Klionsky
Daniel J. Klionsky
HAHagai Abeliovich
Hagai Abeliovich
PAPatrizia Agostinis
Patrizia Agostinis
DADevendra K Agrawal
Devendra K Agrawal
GAGjumrakch Aliev
Gjumrakch Aliev
RDRussell L Deter
Russell L Deter
(2008). Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy: Vol. 4, No. 2, pp. 151-175.

27 August 2004 in Science
Verified
Journal Article
Closed access
PDF file
ACAna Maria Cuervo
Ana Maria Cuervo
LSLeonidas Stefanis
Leonidas Stefanis
RFRoss Fredenburg
Ross Fredenburg
PLPeter T. Lansbury
Peter T. Lansbury
DSDavid Sulzer
David Sulzer
Aberrant α-synuclein degradation is implicated in Parkinson's disease pathogenesis because the protein accumulates in the Lewy inclusion bodies associated with the disease. Little is known, however, about the pathways by which wild-type α-synuclein is normally degraded. We found that wild-type α-synuclein was selectively translocated into lysosomes for degradation by the chaperone-mediated autophagy pathway. The pathogenic A53T and A30P α-synuclein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degradation and that of other substrates. These findings may underlie the toxic gain-of-function by the mutants.

30 August 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DKDaniel J. Klionsky
Daniel J. Klionsky
GPGiulia Petroni
Giulia Petroni
RARavi K Amaravadi
Ravi K Amaravadi
EBEric H Baehrecke
Eric H Baehrecke
ABAndrea Ballabio
Andrea Ballabio
FPFederico Pietrocola
Federico Pietrocola
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.